Geneology International

Tag: call

  • Queen health update: Monarch holds meeting virtually but Boris Johnson call rescheduled | Royal | News

    Queen health update: Monarch holds meeting virtually but Boris Johnson call rescheduled | Royal | News

    Mr Johnson asked to reschedule the simply call as he is abroad. The Primary Minister is at the moment on a 24-hour stop by to Sweden and Finland, exactly where he is speaking about navy aid for the nations. The digital engagement arrives right after the Queen was compelled to terminate her look at the State Opening of Parliament yesterday as a end result of health challenges.

    Prince Charles shipped the Queen’s Speech on her behalf.

    He was accompanied by Prince William, who attended the function for the 1st time.

    Constitutional qualified Bob Morris mentioned that William and Charles’ roles in the ceremony had been “unparalleled”.

    He informed the Mirror that it was “a lot more possible than not” that the preparations would remain in area for long term point out openings.

    Until the day prior to the party, Buckingham Palace experienced continuously reported the Queen nevertheless “hoped” to go to.

    The palace introduced that she experienced “reluctantly” taken the choice to pull out of the celebration, which she has only skipped 2 times before.

    Her spokesperson stated she is continuing to undergo from “episodic mobility challenges”.

    They stated: “The Queen proceeds to encounter episodic mobility problems and in session with her doctors has reluctantly made the decision that she will not attend the Condition Opening of Parliament tomorrow.

    “At Her Majesty’s request, and with the settlement of the applicable authorities, the Prince of Wales will read through the Queen’s Speech on Her Majesty’s behalf, with the Duke of Cambridge also in attendance.”

    The Queen has had to pass up a amount of occasions in current months as a final result of health challenges.

    Final Oct, she was not able to show up at the Remembrance Sunday Services at the Cenotaph.

    She also missed the Easter Sunday Company at St George’s Chapel, even with it staying in the grounds of Windsor Castle.

    Nevertheless, she did deal with to make an visual appearance at Prince Philip’s memorial support, which took location in Westminster Abbey in March.

    The Queen’s decision to miss out on the State Opening of Parliament has sparked fears that the monarch could overlook her personal Jubilee celebrations, getting spot in June.

    A royal resource mentioned that the Queen may perhaps have to “opt for her battles” when it arrives to the celebrations.

    Speaking to the Mirror, they claimed: “There will certainly be fears over regardless of whether Her Majesty will be able to make any activities for her Jubilee celebrations or have to seriously opt for her battles.

    “She will do her most effective but her wellbeing will have to occur 1st and she is by now applied to listening to the assistance of her medical doctors as nicely as realizing her own limitations.”

  • Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre | BMC Women’s Health

    Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre | BMC Women’s Health

  • 1.

    Nelson HD. Menopause. Lancet. 2008;371(9614):760–70.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 2.

    Natari RB, Clavarino AM, McGuire TM, Dingle KD, Hollingworth SA. The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: a systematic review of longitudinal studies. Menopause. 2018;25(1):109–20.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 3.

    Schbley BH. Socioeconomic factors in menopausal women’s use of hormone replacement therapy. J Women Aging. 2009;21(2):99–110.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 4.

    Whiteley J, DiBonaventura M, Wagner JS, Alvir J, Shah S. The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. J Womens Health. 2013;22(11):983–90.

    Article 

    Google Scholar     

  • 5.

    Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.

    Article 

    Google Scholar     

  • 6.

    Committee TWHIS. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s health initiative randomized controlled trial. JAMA. 2004;291(14):1701–12.

    Article 

    Google Scholar     

  • 7.

    Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328(15):1069–75.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 8.

    Stoppe G, Dören M. Critical appraisal of effects of estrogen replacement therapy on symptoms of depressed mood. Arch Women Ment Health. 2002;5(2):39–47.

    CAS 
    Article 

    Google Scholar     

  • 9.

    Brown S. Shock, terror and controversy: how the media reacted to the Women’s health initiative. Climacteric. 2012;15(3):275–80.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 10.

    Lawton B, Rose S, McLeod D, Dowell A. Changes in use of hormone replacement therapy after the report from the Women’s Health Initiative: cross sectional survey of users. BMJ. 2003;327(7419):845.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar     

  • 11.

    Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297(13):1465–77.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 12.

    de Villiers TJ, Hall JE, Pinkerton JV, Cerdas Perez S, Rees M, Yang C, Pierroz DD. Revised global consensus statement on menopausal hormone therapy. Climacteric. 2016;19(4):313–5.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 13.

    Wysowski DK, Governale LA. Use of menopausal hormones in the United States, 1992 through June, 2003. Pharmacoepidemiol Drug Saf. 2005;14(3):171–6.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 14.

    Sarrel PM, Njike VY, Vinante V, Katz DL. The mortality toll of estrogen avoidance: an analysis of excess deaths among hysterectomized women aged 50 to 59 years. Am J Public Health. 2013;103(9):1583–8.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar     

  • 15.

    LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA. 2011;305(13):1305–14.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar     

  • 16.

    Bahri N, Pourali L, Esmaeeli H. Application of various menopausal symptoms treatment options and its related factors, Gonabad- 2016. Iran J Obstet Gynecol Infert. 2016;19(26):1–8.


    Google Scholar     

  • 17.

    Drewe J, Bucher KA, Zahner C. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. Springerplus. 2015;4(1):65.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar     

  • 18.

    Goldstein KM, Coeytaux RR, Williams JW Jr, Shepherd-Banigan M, Goode AP, McDuffie JR, Befus D, Adam S, Masilamani V, Van Noord MG. Non-pharmacologic treatments for menopause-associated vasomotor symptoms. Washington DC: DVA Health Services Research and Development Service; 2016.


    Google Scholar     

  • 19.

    Carpenter JS, Byrne MM, Studts JL. Factors related to menopausal symptom management decisions. Maturitas. 2011;70(1):10–5.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 20.

    Siyam T, Carbon J, Ross S, Yuksel N. Determinants of hormone therapy uptake and decision-making after bilateral oophorectomy (BO): a narrative review. Maturitas. 2019;120:68–76.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 21.

    Hyde A, Nee J, Drennan J, Butler M, Howlett E. Hormone therapy and the medical encounter: a qualitative analysis of women’s experiences. Menopause. 2010;17(2):344–50.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 22.

    Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the women’s health initiative randomized trials. JAMA. 2017;318(10):927–38.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar     

  • 23.

    Langer RD, Hodis HN, Lobo RA, Allison MA. Hormone replacement therapy—where are we now? Climacteric. 2021;24(1):3–10.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 24.

    Thompson JJ, Ritenbaugh C, Nichter M. Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making. BMC Womens Health. 2017;17(1):97.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar     

  • 25.

    Velentzis LS, Banks E, Sitas F, Salagame U, Tan EH, Canfell K. Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: results from a national, cross-sectional study. PLoS ONE. 2016;11(3):e0146494.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar     

  • 26.

    Bahri N, Sajjadi M, Sadeghmoghadam L. The relationship between management strategies for menopausal symptoms and women’s decision making styles during menopausal transition. Prz Menopauzalny. 2019;18(3):174–9.

    PubMed 
    PubMed Central 

    Google Scholar     

  • 27.

    Theroux R. Women’s decision making during the menopausal transition. J Am Acad Nurse Pract. 2010;22(11):612–21.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 28.

    Zapata AML, Beaudreau SA, O’Hara R, Bereknyei Merrell S, Bruce J, Garrison-Diehn C, Gould CE. Information-seeking about anxiety and perceptions about technology to teach coping skills in older veterans. Clin Gerontol. 2017;41(8):346–56.

    PubMed 
    PubMed Central 

    Google Scholar     

  • 29.

    Kingsberg SA, Schaffir J, Faught BM, Pinkerton JV, Parish SJ, Iglesia CB, Gudeman J, Krop J, Simon JA. Female sexual health: barriers to optimal outcomes and a roadmap for improved patient-clinician communications. J Women’s Health (2002). 2019;28(4):432–43.

    Article 

    Google Scholar     

  • 30.

    Henwood F, Wyatt S, Hart A, Smith J. ‘Ignorance is bliss sometimes’: constraints on the emergence of the ‘informed patient’ in the changing landscapes of health information. Sociol Health Illn. 2003;25(6):589–607.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 31.

    Pache DM, Hollingworth SA, van Driel ML, McGuire TM. Does consumer medicines interest reflect medicines use? An Australian observational study comparing medicines call center queries with medicines use. Res Social Adm Pharm. 2019;15(4):440–7.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 32.

    Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, Sørensen HT, von Elm E, Langan SM, Committee RW. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar     

  • 33.

    ATC/DDD Index 2017 https://www.whocc.no/atc_ddd_index/

  • 34.

    Commonwealth Department of Health and Aged Care, National Key Centre for Social Applications of Geographical Information Systems: Measuring remoteness: Accessibility/Remoteness Index of Australia (ARIA) revised edition: Commonwealth Department of Health and Aged Care; 2001.

  • 35.

    Australian Bureau of Statistics: Year book Australia 2012. Canberra: Australian Bureau of Statistics; 2012.

  • 36.

    Beasley TM, Schumacker RE. Multiple regression approach to analyzing contingency tables: Post hoc and planned comparison procedures. J Exp Educ. 1995;64(1):79–93.

    Article 

    Google Scholar     

  • 37.

    Bazeley P. Analysing qualitative data: More than ‘identifying themes.’ Malays J Qual Res. 2009;2(2):6–22.


    Google Scholar     

  • 38.

    Pines A, Sturdee DW, Birkhäuser MH, Schneider HPG, Gambacciani M, Panay N. IMS updated recommendations on postmenopausal hormone therapy. Climacteric. 2007;10(3):181–94.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 39.

    Hengen KM, Alpers GW. What’s the risk? Fearful Individuals generally overestimate negative outcomes and they dread outcomes of specific events. Front Psychol. 2019;10:1676.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar     

  • 40.

    Loewenstein GF, Weber EU, Hsee CK, Welch N. Risk as feelings. Psychol Bull. 2001;127(2):267–86.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 41.

    Shapiro M. Media and education of the consumer. Menopause. 2016;23(8):924–7.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 42.

    Natari RB, McGuire TM, Baker PJ, Clavarino AM, Dingle KD, Hollingworth SA. Longitudinal impact of the Women’s health initiative study on hormone therapy use in Australia. Climacteric. 2019;22(5):489–97.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 43.

    Crawford SL, Crandall CJ, Derby CA, El Khoudary SR, Waetjen LE, Fischer M, Joffe H. Menopausal hormone therapy trends before versus after 2002: impact of the Women’s health initiative study results. Menopause. 2018;26(6):588–97.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar     

  • 44.

    Ettinger B, Wang SM, Leslie RS, Patel BV, Boulware MJ, Mann ME, McBride M. Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause. 2018;25(11):1306–12.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 45.

    Kloosterboer SM, McGuire T, Deckx L, Moses G, Verheij T, van Driel ML. Self-medication for cough and the common cold: Information needs of consumers. Aust Fam Physician. 2015;44(7):497–501.

    PubMed 
    PubMed Central 

    Google Scholar     

  • 46.

    Gartoulla P, Davis S, Worsley R, Bell R. Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40–65 years. Med J Aust. 2015;203(3):146–146.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 47.

    de Villiers TJ, Gass MLS, Haines CJ, Hall JE, Lobo RA, Pierroz DD, Rees M. Global Consensus Statement on menopausal hormone therapy. Maturitas. 2013;74(4):391–2.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar     

  • 48.

    Huston SA, Jackowski RM, Kirking DM. Women’s trust in and use of information sources in the treatment of menopausal symptoms. Womens Health Issues. 2009;19(2):144–53.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar